Overview

Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.

Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Study to examine the safety and effectiveness of implanted skeletal muscle cells (cells removed from the thigh muscle) into scarred areas of heart muscle after heart attack.
Phase:
Phase 2
Details
Lead Sponsor:
Genzyme, a Sanofi Company